Advertising space rental

Notice of Clinical Trial Approval for Recombinant Human Adenovirus 5 Injection of Shanghai Pharmaceuticals Group Co., Ltd. Restructuring

Notice of Clinical Trial Approval for Recombinant Human Adenovirus 5 Injection of Shanghai Pharmaceuticals Group Co., Ltd. Restructuring

Recombinant human adenovirus type 5 injection (trade name: Ankrui) is an oncolytic adenovirus anti-tumor drug that contains recombinant adenoviruses that can specifically replicate in tumor cells, cause tumor cell damage, lysis, and further activate immune responses to exert anti-tumor effects. Ankeri was approved for marketing in China in 2005, with an approved indication for advanced nasopharyngeal carcinoma...

Eli Lilly announces the complete phase III data of new drugs for Alzheimer's disease, which may compete with Eisai at the end of the year

Eli Lilly announces the complete phase III data of new drugs for Alzheimer's disease, which may compete with Eisai at the end of the year

TRAILBLAZER-ALZ2 Design of experiments and summary of results. Image source: Journal of the American Medical AssociationOn July 17 local time, the United States Lilly (LLY...

Advertising space rental